Catherine Novack

Stock Analyst at Jones Trading

(0.27)
# 2687
Out of 5,380 analysts
24
Total ratings
Success rate
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
FEMY Femasys
Maintains: Buy
10 6
0.89 574.16% 2 May 13, 2025
RGLS Regulus Therapeutics
Downgrades: Hold
8 7
8.16 -14.22% 2 Apr 30, 2025
RLYB Rallybio
Downgrades: Hold
n/a
n/a n/a 1 Apr 15, 2025
PVLA Palvella Therapeutic...
Initiates Coverage On: Buy
45
21.94 105.1% 1 Mar 25, 2025
PRQR ProQR Therapeutics
Initiates Coverage On: Buy
11
2.02 444.55% 1 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
130
12.68 925.24% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
40
9.16 336.68% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 16
6.86 133.24% 2 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
2.98 369.8% 1 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 13
2.67 386.89% 2 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
4.26 134.74% 1 Apr 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
1.62 1258.02% 1 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
160
n/a n/a 1 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
n/a n/a 1 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
n/a n/a 1 Oct 4, 2021